Clostridium difficile disease
Showing 9976 - 10000 of >10,000
COVID-19 Trial in Yaoundé, Nairobi (Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics)
Not yet recruiting
- COVID-19
- Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics
-
Yaoundé, Cameroon
- +1 more
Aug 16, 2022
NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- N-803 + Pembrolizumab
- +9 more
-
Anchorage, Alaska
- +34 more
Apr 4, 2022
Adolescent Idiopathic Scoliosis Trial in Istanbul (Home Based Traditional Scoliosis Exercises, Core Stability Training)
Completed
- Adolescent Idiopathic Scoliosis
- Home Based Traditional Scoliosis Exercises
- Core Stability Training
-
Istanbul, Fatih, TurkeyIstanbul University
Mar 25, 2022
Type 1 Diabetes Trial in Copenhagen (Rapidly declining plasma glucose, Slowly declining plasma glucose)
Active, not recruiting
- Type 1 Diabetes
- Rapidly declining plasma glucose
- Slowly declining plasma glucose
-
Copenhagen, DenmarkSteno Diabetes Center Copenhagen - Gentofte Hospital
May 12, 2022
Breast Cancer, Breast Tumor Trial in Saint Louis (Endocare SlimLine Cryoprobe, Lumpectomy)
Not yet recruiting
- Breast Cancer
- Breast Neoplasm
- Endocare SlimLine Cryoprobe
- Lumpectomy
-
Saint Louis, MissouriWashington University School of Medicine
Aug 15, 2022
Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)
Recruiting
- Squamous Cell Carcinoma
- Standard surveillance
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022
Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)
Completed
- Adult Acute Lymphocytic Leukemia
- Cyclophosphamide
- +20 more
-
Frankfurt, GermanyUniversity of Frankfurt, Medical Dept. II
Aug 17, 2022
Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous
Recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaLiuxiqiang
Feb 1, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023
Diabetic Kidney Disease Trial in Australia (SER150, Placebo)
Recruiting
- Diabetic Kidney Disease
- SER150
- Placebo
-
Liverpool, New South Wales, Australia
- +6 more
May 17, 2022
Alcohol Use Disorder, Alcoholic Liver Disease, Microbiome Trial in Los Angeles (VSL #3 112.5 Capsule, Placebo)
Recruiting
- Alcohol Use Disorder
- +2 more
- VSL #3 112.5 Capsule
- Placebo
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 16, 2022
Kidney Diseases Trial in Beijing
Recruiting
- Kidney Diseases
-
Beijing, Beijing, ChinaGeorge Clinical (Beijing)
Dec 15, 2021
Vitamin K Deficiency Trial in Aachen (Vitamin K supplement)
Completed
- Vitamin K Deficiency
- Vitamin K supplement
-
Aachen, GermanyRWTH Aachen University
Apr 29, 2022
NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
- (no location specified)
Mar 7, 2023
Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)
Coronary Small Vessel Disease Trial in China (Cohort A: Dissolve™, Cohort A: Resolute™ Integrity, Cohort B: Dissolve™-2.00mm)
Active, not recruiting
- Coronary Small Vessel Disease
- Cohort A: Dissolve™
- +2 more
-
Beijing, China
- +14 more
Feb 16, 2022
Respiratory Complications in ALS
Completed
- Motor Neuron Disease
- Pneumonia
- Questionaires
-
Liverpool, United KingdomLiverpoolUHNHS
Sep 21, 2021
Sickle Cell Disease, Attention Deficit, Cognitive Deficit in Attention Trial (EndeavorRx)
Not yet recruiting
- Sickle Cell Disease
- +2 more
- EndeavorRx
- (no location specified)
Oct 3, 2022
Depression, Anxiety, Coronary Artery Disease Trial in Drammen (Attention Training Technique)
Recruiting
- Depression, Anxiety
- Coronary Artery Disease
- Attention Training Technique
-
Drammen, Viken County, NorwayVestre Viken Trust Drammen hospital
Jan 25, 2023
Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Barotrauma
- Blood and bronchoalveolar fluid collection and analysis
- Chest CT scan
-
Cagliari, Italy
- +3 more
Aug 17, 2023
Coagulation Disorders on the Diagnosis and Prognosis of Sepsis
Recruiting
- Sepsis
- Coagulation Disorder
- Early general coagulation function (5 items of coagulation) and thromboelastogram monitoring
-
Shanghai, Shanghai, ChinaDepartment of Emergency, Ruijin Hospital, Shanghai Jiao Tong Uni
Aug 17, 2023
Platelet Adhesion in the Pathobiology of Aortic Stenosis
Not yet recruiting
- Aortic Valve Stenosis
- Echocardiogaphy
-
Charlottesville, VirginiaUniversity of Virginia
Sep 19, 2022